Skip to main content

RETRACTION article

Front. Pharmacol., 06 July 2023
Sec. Gastrointestinal and Hepatic Pharmacology
Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1252183
This article is part of the Research Topic Natural Product Treatment of Gastrointestinal Diseases View all 11 articles

Retraction: Quercetin inhibits tumorigenesis of colorectal cancer through downregulation of hsa_circ_0006990

This article is a retraction of:

  1. RETRACTED: Quercetin Inhibits Tumorigenesis of Colorectal Cancer Through Downregulation of hsa_circ_0006990

    1. Read original article
Frontiers Editorial Office Frontiers Editorial Office*

A Retraction of the Original Research Article
Quercetin inhibits tumorigenesis of colorectal cancer through downregulation of hsa_circ_0006990

by Chen B, Wu L, Tang X, Wang T, Wang S, Yu H, Wan G, Xie M, Zhang R, Xiao H and Deng W (2022). Front. Pharmacol. 13:874696. doi: 10.3389/fphar.2022.874696

Following publication, the authors contacted the Editorial Office to request the retraction of the cited article, stating that cell lines used in the article were contaminated by Mycoplasma. It was confirmed by the authors when they tried to repeat their experiments unsuccessfully. The findings and conclusions reported in the article are no longer supported by the data. An investigation was conducted in accordance with Frontiers’ policies that confirmed this; therefore, the article has been retracted.

This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. The authors agree to this retraction.

Citation: Frontiers Editorial Office (2023) Retraction: Quercetin inhibits tumorigenesis of colorectal cancer through downregulation of hsa_circ_0006990. Front. Pharmacol. 14:1252183. doi: 10.3389/fphar.2023.1252183

Received: 03 July 2023; Accepted: 03 July 2023;
Published: 06 July 2023.

Approved by:

Angelo A. Izzo, University of Naples Federico II, Italy

Copyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.